For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Trevi Therapeutics Inc (NASDAQ: TRVI) closed at $3.96 down -2.46% from its previous closing price of $4.06. In other words, the price has decreased by -$2.46 from its previous closing price. On the day, 0.56 million shares were traded. TRVI stock price reached its highest trading level at $4.04 during the session, while it also had its lowest trading level at $3.79.
Ratios:
For a deeper understanding of Trevi Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.38 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 12, 2024, Reiterated its Buy rating but revised its target price to $7.50 from $6 previously.
On August 30, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $9.Raymond James initiated its Outperform rating on August 30, 2024, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 06 ’24 when GOOD JENNIFER L sold 4,219 shares for $3.03 per share. The transaction valued at 12,784 led to the insider holds 213,313 shares of the business.
GOOD JENNIFER L sold 1,840 shares of TRVI for $5,587 on Sep 09 ’24. The President & CEO now owns 213,313 shares after completing the transaction at $3.04 per share. On Sep 05 ’24, another insider, GOOD JENNIFER L, who serves as the President & CEO of the company, sold 40,277 shares for $3.11 each. As a result, the insider received 125,310 and left with 213,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRVI now has a Market Capitalization of 353888160 and an Enterprise Value of 240008208.
Stock Price History:
The Beta on a monthly basis for TRVI is 0.93, which has changed by 0.9150944 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, TRVI has reached a high of $4.68, while it has fallen to a 52-week low of $1.65. The 50-Day Moving Average of the stock is 4.70%, while the 200-Day Moving Average is calculated to be 26.54%.
Shares Statistics:
For the past three months, TRVI has traded an average of 1.75M shares per day and 497280 over the past ten days. A total of 75.45M shares are outstanding, with a floating share count of 58.05M. Insiders hold about 35.04% of the company’s shares, while institutions hold 35.96% stake in the company. Shares short for TRVI as of 1738281600 were 4592706 with a Short Ratio of 2.36, compared to 1735603200 on 3866770. Therefore, it implies a Short% of Shares Outstanding of 4592706 and a Short% of Float of 7.4099995000000005.
